Ulipristal News
Ulipristal currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Ulipristal with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Emergency contraception within 120 hours (five days) of unprotected sexual intercourse or contraceptive failure.
- Evidence level: L5
- Predicted indications (20):
- rheumatoid arthritis (90.3%)
- primary release disorder of platelets (89.7%)
- tendinitis (89.0%)
- myositis fibrosa (88.0%)
- idiopathic granulomatous myositis (88.0%)
- pseudo-von Willebrand disease (87.2%)
- Glanzmann thrombasthenia (87.0%)
- brachydactyly-syndactyly syndrome (86.8%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (86.1%)
- fibromyalgia (85.6%)
- heart neoplasm (85.0%)
- scalp dermatosis (84.6%)
- thrombotic disease (83.8%)
- indolent plasma cell myeloma (83.8%)
- inclusion body myositis (83.5%)
- amenorrhea (disease) (82.9%)
- heart conduction disease (82.4%)
- plasma cell myeloma (82.3%)
- congenital anomaly of ventricular septum (82.1%)
- conjunctivitis (82.0%)
Related News (2)
A surprisingly simple way to relieve knee arthritis pain without pills or surgery - Science Daily
2026-10-11 arthritis
Source: Science Daily
Knee pain and crunching: 3 exercises to ease osteoarthritis of the kneecap - South China Morning Post
2026-10-09 arthritis
Source: South China Morning Post
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.